Biochemical markers of bone turnover and clinical outcomes in men with prostate cancer Review uri icon

Overview

MeSH Major

  • Biomarkers
  • Bone Neoplasms
  • Bone and Bones
  • Collagen Type I
  • Peptides
  • Prostatic Neoplasms

abstract

  • Bone marker levels reflect ongoing skeletal metabolism and can provide important insights into bone health and response to bisphosphonate therapy in patients with prostate cancer. The data supporting a role for bone markers to monitor skeletal disease progression and response to zoledronic acid therapy are especially strong. Bone marker assessments may complement established diagnostic and monitoring paradigms in prostate cancer.

publication date

  • July 2012

Research

keywords

  • Review

Identity

Language

  • eng

PubMed Central ID

  • PMC3107360

Digital Object Identifier (DOI)

  • 10.1016/j.urolonc.2010.08.007

PubMed ID

  • 21163673

Additional Document Info

start page

  • 369

end page

  • 78

volume

  • 30

number

  • 4